About
The diagnosis of brain tumours is currently based on neuro-imaging and tissue biopsy. Brain biopsy is invasive and associated with diverse risks depending on the size and accessibility of the target. Non-invasive biomarkers could provide a complement and an early solution to monitoring brain tumours. WG1 discovers sensitive and specific brain cancer biomarkers in liquid biopsy as well as radiomics biomarkers.
Research focus
Non Invasive Biomarker Discovery
The diagnosis of brain tumours is currently based on neuro-imaging and tissue biopsy. Brain biopsy is invasive and associated with diverse risks depending on the size and accessibility of the target. Non-invasive biomarkers could provide a complement and an early solution to monitoring brain tumours. WG1 discovers sensitive and specific brain cancer biomarkers in liquid biopsy as well as radiomics biomarkers.